Company intelligence / Profile preview

Dragonfly Biosciences

London, United Kingdom

Ownership: Private
Development stage: Other

Overview

Dragonfly Biosciences develops and markets seed‑to‑shelf cannabidiol (CBD) wellness products (primarily oils and skincare) using hemp-derived CBD with minimal THC, distributed through major UK and international retailers. It focuses on consumer health and wellness rather than regulated prescription pharmaceuticals.[1][3][4][5]

Therapeutic areas: RheumatologyPsychiatryNeurologyDermatology
Modalities: Non-pharmacological therapy
Industry: Agriculture & AgTech

Partnerships

Boots (UK retail partner)[3]Sainsbury's (UK retail partner)[3]Harrods (UK retail partner)[3]Amazon UK (retail channel)[3]Superdrug (UK retail partner)[3]Thought Leaders Inc. (exclusive US master licensee)[4]

Beyond the preview

Go deeper on Dragonfly Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dragonfly Biosciences.

Explore the full profile